Masonic Cancer Center, University of Minnesota
S

Senescence-Associated Secretory Phenotype-Aging Index and All-Cause Mortality in Cancer Survivors

By Masonic Cancer Center, University of Minnesota FEATURING Shuo Wang
By Masonic Cancer Center, University of Minnesota FEATURING Shuo Wang
29 views
January 19, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
15:11
Insights from 2024 ACP Annual Meeting

ACP 2024 Insights: Cancer of Unknown Primary

Feat. S. Brondfield
28:21
Houston Methodist Hospital

Palliative Medicine in Cancer Patients

Feat. E. De Leon
09:28
Yale Cancer Center

The Future of Lung Cancer Care

Feat. M. Davies
10:07
Oncology Data Advisor

The Importance of Exercise for Cancer Survivorship

Feat. N. Seetharamu
23:38
2023 West Oncology Conference

Improving the Quality of Life for Head & Neck Cancer Survivors: …

Feat. B. Murphy
04:04
Dana-Farber Cancer Institute

Metastatic Disease Survivors - mBC Series

Feat. H. Burstein
27:49
Yale Cancer Center

Exercise as Standard of Care for Breast Cancer

Feat. M. Irwin, T. Sanft
19:36
Dana-Farber Cancer Institute

Hot Topics in Nutrition: A Comparison of the Blue Zone Diet and Canc…

Feat. J. Bosworth
08:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Organ Preserving and Reconstructive Surge…

Feat. A. Burnett
40:13
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Diagnosis and Treatment of Hodgkin's Lymphoma

Feat. R. C. Lynch
20:14
Total Health

Sexual Health and Cancer

Feat. A. Siston
13:16
Vanderbilt University Medical Center (VUMC)

Nutrition Considerations in Survivorship

Feat. S. Pavelka
98:16
Scripps Health

Natural Medicines in Cancer Survivorship Care

Feat. D. Leopold
48:12
Yale Cancer Center

Lymphocytes as a "Living Drug" for the Treatment of Cancer

Feat. S. Rosenberg
26:57
Total Health

Germline Genetic Testing for Cancer Risk and Cancer Therapeutics

Feat. J. Ford
42:09
Masonic Cancer Center, University of Minnesota

Hormone Deficiencies After Cancer: Diagnosis, Risks, & Benefits …

Feat. B. Miller
28:40
Indy Hematology Review

Management of Long-Term Survivors of Hematologic Malignancies in 2024

Feat. S. Garofalo
08:36
i3 Health

Recurrent and Metastatic HNSCC: New Insights and Real-World Evidence…

Feat. A. Sacco
37:04
Nebraska Oncology Society

Survivorship After Transplant and CAR-T for Hematologic Malignancies

Feat. N. Ahmed
29:25
UChicago Medicine 12th International Clinical Cancer Genomics Conference

Li-Fraumeni Syndrome as a Case Study of the Effect of Early Diagnosi…

Feat. J. Garber